Vancouver, WA, United States of America

Amir Shanehsazzadeh

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Absci LLC. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amir Shanehsazzadeh. Retrieved from https://idiyas.com/inventor/amir-shanehsazzadeh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Amir Shanehsazzadeh: Innovator in Antibody Compositions

Introduction

Amir Shanehsazzadeh is a notable inventor based in Vancouver, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody compositions.

Latest Patents

Amir holds a patent for "TL1A Associated Antibody Compositions and Methods of Use." This patent reflects his innovative approach to creating therapeutic solutions that can potentially address various medical conditions.

Career Highlights

Amir is currently employed at Absci LLC, a company that focuses on advancing protein-based therapeutics. His work at Absci LLC has positioned him as a key player in the biotechnology sector.

Collaborations

Amir collaborates with talented individuals such as Sharrol Bachas and Simon Levine-Gottreich. These partnerships enhance the innovative environment at Absci LLC and contribute to the development of groundbreaking solutions.

Conclusion

Amir Shanehsazzadeh's work in antibody compositions showcases his dedication to advancing medical science. His contributions are paving the way for future innovations in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…